Table 2.
Treatment | KEGG pathways | Gene |
---|---|---|
T1vsCK | Steroid biosynthesis(map00100) | 1 |
T1vsCK | Selenocompound metabolism(map00450) | 1 |
T1vsCK | Protein processing in endoplasmic reticulum(map04141) | 1 |
T1vsCK | Pentose and glucuronate interconversions(map00040) | 1 |
T1vsCK | mRNA surveillance pathway(map03015) | 1 |
T1vsCK | Glycolysis/Gluconeogenesis(map00010) | 1 |
T1vsCK | Amino sugar and nucleotide sugar metabolism(map00520) | 1 |
T2vsCK | Ubiquitin mediated proteolysis(map04120) | 1 |
T2vsCK | Steroid biosynthesis(map00100) | 2 |
T2vsCK | RNA transport(map03013) | 1 |
T2vsCK | Plant-pathogen interaction(map04626) | 2 |
T2vsCK | Peroxisome(map04146) | 1 |
T2vsCK | Other glycan degradation(map00511) | 1 |
T2vsCK | Metabolic pathways(map01100) | 5 |
T2vsCK | Isoquinoline alkaloid biosynthesis(map00950) | 2 |
T2vsCK | Endocytosis(map04144) | 2 |
T2vsCK | Biosynthesis of secondary metabolites(map01110) | 14 |
T2vsCK | Ascorbate and aldarate metabolism(map00053) | 2 |
T2vsCK | alpha-Linolenic acid metabolism(map00592) | 3 |
T2vsT1 | Stilbenoid, diarylheptanoid and gingerol biosynthesis(map00945) | 1 |
T2vsT1 | Phenylpropanoid biosynthesis(map00940) | 1 |
T2vsT1 | Phenylalanine metabolism(map00360) | 1 |
T2vsT1 | Glutathione metabolism(map00480) | 1 |
CK: control, T1: moderate stress, T2: severe stress.